Inferra AI / Company / G
Genpact Ltd
G · Industrials
Last earnings Aug 6, 2026
Key results
Net revenuequarter
$1.254 billion
Net Revenues of $1.254 billion, Up 6.6% (6.2% constant currency) 1
SEC original ↗Genpact Ltd — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Growthquarter
Up 6.6%
Net Revenues of $1.254 billion, Up 6.6% (6.2% constant currency) 1
SEC original ↗Genpact Ltd — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Data-Tech-AI Net revenuequarter
$599 million
Data-Tech-AI Net Revenues of $599 million, Up 9.7% (9.5% constant currency) 1
SEC original ↗Genpact Ltd — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Digital Operations Net revenuequarter
$655 million
Digital Operations Net Revenues of $655 million, Up 4.0% (3.4% constant currency)
SEC original ↗Genpact Ltd — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Revenuequarter
7%
Second quarter revenue increased 7% year-over-year, driven by accelerating growth in Advanced Technology Solutions, up 17%.
SEC original ↗Genpact Ltd — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Key Financial Highlights Second Quarter 2025 Net revenues were $1.254 billion, up 6.6% year-over-year, and up 6.2% on a constant currency basis.
SEC original ↗Genpact Ltd — Earnings release (8-K exhibit)EX-99Aug 7, 2025
1 Data-Tech-AI net revenues were $599 million, up 9.7% year-over-year, and up 9.5% on a constant currency basis, 1 representing 48% of total net revenues.
SEC original ↗Genpact Ltd — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Digital Operations net revenues were $655 million, up 4.0% year-over-year, and up 3.4% on a constant currency basis, 1 representing 52% of total net revenues.
SEC original ↗Genpact Ltd — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Advanced Technology Solutions net revenues 2 were $293 million, up 17.3% year-over-year, representing 23% of total net revenues.
SEC original ↗Genpact Ltd — Earnings release (8-K exhibit)EX-99Aug 7, 2025
AI analysis
Q2 2025 · reported Aug 7, 2025
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
The quarter in charts
Segment mix
Business-unit revenue, as stated
Segment revenue figures as stated in the event record.
Headline figures
| Metric | Q2 2025 | Prior qtr | Year ago |
|---|---|---|---|
| Net revenue | $1.254 billion | — | — |
| Growth | Up 6.6% | — | — |
| Data-Tech-AI Net revenue | $599 million | — | — |
| Digital Operations Net revenue | $655 million | — | — |
| Revenue | 7% | — | — |
Guidance · company-stated
Direction: Raised
“For the full year, we are increasing guidance, with 5% revenue growth now expected at the midpoint of the range and adjusted diluted EPS again growing faster than revenue, said Balkrishan BK Kalra, Genpact's President and CEO .”
Classified from the release's primary full-year outlook statement.
Capital allocation
Genpact repurchased approximately 700,000 common shares during the quarter for total consideration of approximately $30 million at an average price per share of $43.40.
In addition to this program, the Company uses derivative instruments that are not accounted for as hedges under FASB guidance in order to hedge foreign exchange risks related to balance sheet items, such as receivables and intercompany borrowings, that are denominated in currencies other than the Company s underlying functional currency.
Event summary
We delivered another strong quarter, with results above the high end of our guidance range, reflecting healthy growth driven by GenpactNext
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
Direction: Raised
Revenue: “For the full year, we are increasing guidance, with 5% revenue growth now expected at the midpoint of the range and adjusted diluted EPS again growing faster than revenue, said Balkrishan BK Kalra, Genpact's President and CEO .”
Revenue — Raised (“increasing”)
“For the full year, we are increasing guidance, with 5% revenue growth now expected at the midpoint of the range and adjusted diluted EPS again growing faster than revenue, said Balkrishan BK Kalra, Genpact's President and CEO .”
Classified from the release's primary full-year outlook statement.
Capital allocation
Genpact repurchased approximately 700,000 common shares during the quarter for total consideration of approximately $30 million at an average price per share of $43.40.
SEC original ↗Genpact Ltd — Earnings release (8-K exhibit)EX-99Aug 7, 2025
In addition to this program, the Company uses derivative instruments that are not accounted for as hedges under FASB guidance in order to hedge foreign exchange risks related to balance sheet items, such as receivables and intercompany borrowings, that are denominated in currencies other than the Company s underlying functional currency.
SEC original ↗Genpact Ltd — 10-Q Quarterly report10-QAug 7, 2026
Short-term borrowings The Company has the following borrowing facilities: a.
SEC original ↗Genpact Ltd — 10-Q Quarterly report10-QAug 7, 2026
A fund-based and non-fund based revolving credit facility of $ 650,000 , which the Company obtained by entering into an amended and restated credit agreement (the "2022 Credit Agreement") with Genpact USA, Genpact Global Holdings (Bermuda) Limited ("GGH") and Genpact Luxembourg, each wholly owned subsidiaries of the Company (Genpact Luxembourg, Genpact USA and GGH, collectively, the "Borrowers"), as borrowers, Wells Fargo, National Association ("Wells Fargo"), as administrative agent, swingline lender and issuing bank, and the lenders and other parties thereto on December 13, 2022.
SEC original ↗Genpact Ltd — 10-Q Quarterly report10-QAug 7, 2026
Strategy & priorities
Looking ahead, our simple yet powerful strategy to integrate Advanced Technology Solutions and strengthen our last mile advantage positions Genpact as a clear partner of choice for AI-driven transformation, accelerating growth for our clients and ourselves.
SEC original ↗Genpact Ltd — Earnings release (8-K exhibit)EX-99Aug 7, 2025
2 Advanced Technology Solutions net revenues include revenues from solutions and services focused on data and AI, digital technology, advisory and agentic solutions.
SEC original ↗Genpact Ltd — Earnings release (8-K exhibit)EX-99Aug 7, 2025
" This ASU clarifies certain aspects of the guidance on hedge accounting and addresses several incremental hedge accounting issues arising from the global reference rate reform initiative.
SEC original ↗Genpact Ltd — 10-Q Quarterly report10-QAug 7, 2026
This acquisition adds differentiated domain-led data strategy, design, and engineering capabilities, deep industry experience, and strategic partnerships.
SEC original ↗Genpact Ltd — 10-Q Quarterly report10-QAug 7, 2026
It also builds on the Company's pivot to data, AI, and other advanced technologies, enhancing the Company's ability to help its clients across the lifecycle of AI transformation, from strategy through implementation.
SEC original ↗Genpact Ltd — 10-Q Quarterly report10-QAug 7, 2026
Risks & headwinds
These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially from those in such forward-looking statements.
SEC original ↗Genpact Ltd — Earnings release (8-K exhibit)EX-99Aug 7, 2025
These risks, uncertainties, and other factors include but are not limited to macroeconomic uncertainty, U.
SEC original ↗Genpact Ltd — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Significant items subject to such estimates and assumptions include the useful lives of property, plant and equipment and intangible assets, transaction prices (including variable consideration) of the Company's revenue contracts, allowances for credit losses, valuation allowances for deferred tax assets, valuation of derivative financial instruments, measurements of lease liabilities and right-of-use ( ROU ) assets, measurements of stock-based compensation, assets and obligations related to employee benefits, the nature and timing of the satisfaction of performance obligations, income tax uncertainties and other contingencies.
SEC original ↗Genpact Ltd — 10-Q Quarterly report10-QAug 7, 2026
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
30 documents- Q2 2026
- 8-K/AG
Sep 18, 2026
- 8-KG
Sep 8, 2026
- 10-QG
Aug 7, 2026
- 8-KG
Aug 6, 2026
- Q1 2026
- 10-QG
May 8, 2026
- 8-KG
May 7, 2026
- 8-KG
Apr 29, 2026
- Q4 2025
- 10-KG
Feb 26, 2026
- 8-KG
Feb 5, 2026
- Q3 2025
- 8-KG
Nov 18, 2025
- 10-QG
Nov 7, 2025
- 8-KG
Nov 6, 2025
- Q2 2025
- 8-KG
Sep 30, 2025
- 8-KG
Sep 12, 2025
- 10-QG
Aug 11, 2025
- 8-KG
Aug 7, 2025
- 8-KG
Aug 5, 2025
- 8-KG
Jul 1, 2025
- Q1 2025
- 8-KG
May 28, 2025
- 10-QG
May 12, 2025
- 8-KG
May 7, 2025
- Q4 2024
- 10-KG
Mar 3, 2025
- 8-KG
Feb 6, 2025
- Q3 2024
- 10-QG
Nov 12, 2024
- 8-KG
Nov 7, 2024
- Q2 2024
- 10-QG
Aug 9, 2024
- 8-KG
Aug 8, 2024
- 8-KG
Aug 8, 2024
- Q1 2024
- 8-KG
Jun 4, 2024
- 10-QG
May 10, 2024
Earnings releases
9 documentsPresentations
0 documentsNo presentations for Genpact Ltd are held in this edition of the library.
Transcripts
0 documentsNo transcripts for Genpact Ltd are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.